Inflammatory Mediators and Angiogenic Factors in Choroidal Neovascularization: Pathogenetic Interactions and Therapeutic Implications

Choroidal neovascularization (CNV) is a common and severe complication in heterogeneous diseases affecting the posterior segment of the eye, the most frequent being represented by age-related macular degeneration. Although the term may suggest just a vascular pathological condition, CNV is more prop...

Full description

Saved in:
Bibliographic Details
Main Authors: Claudio Campa, Ciro Costagliola, Carlo Incorvaia, Carl Sheridan, Francesco Semeraro, Katia De Nadai, Adolfo Sebastiani, Francesco Parmeggiani
Format: Article
Language:English
Published: Wiley 2010-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2010/546826
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832564681894526976
author Claudio Campa
Ciro Costagliola
Carlo Incorvaia
Carl Sheridan
Francesco Semeraro
Katia De Nadai
Adolfo Sebastiani
Francesco Parmeggiani
author_facet Claudio Campa
Ciro Costagliola
Carlo Incorvaia
Carl Sheridan
Francesco Semeraro
Katia De Nadai
Adolfo Sebastiani
Francesco Parmeggiani
author_sort Claudio Campa
collection DOAJ
description Choroidal neovascularization (CNV) is a common and severe complication in heterogeneous diseases affecting the posterior segment of the eye, the most frequent being represented by age-related macular degeneration. Although the term may suggest just a vascular pathological condition, CNV is more properly definable as an aberrant tissue invasion of endothelial and inflammatory cells, in which both angiogenesis and inflammation are involved. Experimental and clinical evidences show that vascular endothelial growth factor is a key signal in promoting angiogenesis. However, many other molecules, distinctive of the inflammatory response, act as neovascular activators in CNV. These include fibroblast growth factor, transforming growth factor, tumor necrosis factor, interleukins, and complement. This paper reviews the role of inflammatory mediators and angiogenic factors in the development of CNV, proposing pathogenetic assumptions of mutual interaction. As an extension of this concept, new therapeutic approaches geared to have an effect on both the vascular and the extravascular components of CNV are discussed.
format Article
id doaj-art-4b0e966a32cf4714a897ad14340ef831
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2010-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-4b0e966a32cf4714a897ad14340ef8312025-02-03T01:10:28ZengWileyMediators of Inflammation0962-93511466-18612010-01-01201010.1155/2010/546826546826Inflammatory Mediators and Angiogenic Factors in Choroidal Neovascularization: Pathogenetic Interactions and Therapeutic ImplicationsClaudio Campa0Ciro Costagliola1Carlo Incorvaia2Carl Sheridan3Francesco Semeraro4Katia De Nadai5Adolfo Sebastiani6Francesco Parmeggiani7Department of Ophthalmology, University of Ferrara, Corso Giovecca 203, 44121 Ferrara, ItalyDepartment of Health Sciences, University of Molise, Campobasso, ItalyDepartment of Ophthalmology, University of Ferrara, Corso Giovecca 203, 44121 Ferrara, ItalySt Paul's Eye Unit, Royal Liverpool University Hospital, Liverpool, UKDepartment of Ophthalmology, University of Brescia, Brescia, ItalyDepartment of Ophthalmology, University of Ferrara, Corso Giovecca 203, 44121 Ferrara, ItalyDepartment of Ophthalmology, University of Ferrara, Corso Giovecca 203, 44121 Ferrara, ItalyDepartment of Ophthalmology, University of Ferrara, Corso Giovecca 203, 44121 Ferrara, ItalyChoroidal neovascularization (CNV) is a common and severe complication in heterogeneous diseases affecting the posterior segment of the eye, the most frequent being represented by age-related macular degeneration. Although the term may suggest just a vascular pathological condition, CNV is more properly definable as an aberrant tissue invasion of endothelial and inflammatory cells, in which both angiogenesis and inflammation are involved. Experimental and clinical evidences show that vascular endothelial growth factor is a key signal in promoting angiogenesis. However, many other molecules, distinctive of the inflammatory response, act as neovascular activators in CNV. These include fibroblast growth factor, transforming growth factor, tumor necrosis factor, interleukins, and complement. This paper reviews the role of inflammatory mediators and angiogenic factors in the development of CNV, proposing pathogenetic assumptions of mutual interaction. As an extension of this concept, new therapeutic approaches geared to have an effect on both the vascular and the extravascular components of CNV are discussed.http://dx.doi.org/10.1155/2010/546826
spellingShingle Claudio Campa
Ciro Costagliola
Carlo Incorvaia
Carl Sheridan
Francesco Semeraro
Katia De Nadai
Adolfo Sebastiani
Francesco Parmeggiani
Inflammatory Mediators and Angiogenic Factors in Choroidal Neovascularization: Pathogenetic Interactions and Therapeutic Implications
Mediators of Inflammation
title Inflammatory Mediators and Angiogenic Factors in Choroidal Neovascularization: Pathogenetic Interactions and Therapeutic Implications
title_full Inflammatory Mediators and Angiogenic Factors in Choroidal Neovascularization: Pathogenetic Interactions and Therapeutic Implications
title_fullStr Inflammatory Mediators and Angiogenic Factors in Choroidal Neovascularization: Pathogenetic Interactions and Therapeutic Implications
title_full_unstemmed Inflammatory Mediators and Angiogenic Factors in Choroidal Neovascularization: Pathogenetic Interactions and Therapeutic Implications
title_short Inflammatory Mediators and Angiogenic Factors in Choroidal Neovascularization: Pathogenetic Interactions and Therapeutic Implications
title_sort inflammatory mediators and angiogenic factors in choroidal neovascularization pathogenetic interactions and therapeutic implications
url http://dx.doi.org/10.1155/2010/546826
work_keys_str_mv AT claudiocampa inflammatorymediatorsandangiogenicfactorsinchoroidalneovascularizationpathogeneticinteractionsandtherapeuticimplications
AT cirocostagliola inflammatorymediatorsandangiogenicfactorsinchoroidalneovascularizationpathogeneticinteractionsandtherapeuticimplications
AT carloincorvaia inflammatorymediatorsandangiogenicfactorsinchoroidalneovascularizationpathogeneticinteractionsandtherapeuticimplications
AT carlsheridan inflammatorymediatorsandangiogenicfactorsinchoroidalneovascularizationpathogeneticinteractionsandtherapeuticimplications
AT francescosemeraro inflammatorymediatorsandangiogenicfactorsinchoroidalneovascularizationpathogeneticinteractionsandtherapeuticimplications
AT katiadenadai inflammatorymediatorsandangiogenicfactorsinchoroidalneovascularizationpathogeneticinteractionsandtherapeuticimplications
AT adolfosebastiani inflammatorymediatorsandangiogenicfactorsinchoroidalneovascularizationpathogeneticinteractionsandtherapeuticimplications
AT francescoparmeggiani inflammatorymediatorsandangiogenicfactorsinchoroidalneovascularizationpathogeneticinteractionsandtherapeuticimplications